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Abstract
Our laboratory and others have shown that overexpression of Dlx5 stimulates osteoblast differentiation. Dlx5−/−/Dlx6−/− mice have more
severe craniofacial and limb defects than Dlx5−/−, some of which are potentially due to defects in osteoblast maturation. We wished to investigate
the degree to which other Dlx genes compensate for the lack of Dlx5, thus allowing normal development of the majority of skeletal elements in
Dlx5−/− mice. Dlx gene expression in cells from different stages of the osteoblast lineage isolated by FACS sorting showed that Dlx2, Dlx5 and
Dlx6 are expressed most strongly in less mature osteoblasts, whereas Dlx3 is very highly expressed in differentiated osteoblasts and osteocytes. In
situ hybridization and Northern blot analysis demonstrated the presence of endogenous Dlx3 mRNA within osteoblasts and osteocytes. Dlx3
strongly upregulates osteoblastic markers with a potency comparable to Dlx5. Cloned chick or mouse Dlx6 showed stimulatory effects on
osteoblast differentiation. Our results suggest that Dlx2 and Dlx6 have the potential to stimulate osteoblastic differentiation and may compensate
for the absence of Dlx5 to produce relatively normal osteoblastic differentiation in Dlx5 knockout mice, while Dlx3 may play a distinct role in late
stage osteoblast differentiation and osteocyte function.
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Extant vertebrates consist of gnathostomes (jawed verte-
brates) and cyclostomes (jawless vertebrates), and the diver-
gence of these two lineages is to a large degree characterized by
the gnathostome's elaboration of the body plan to include bone,
teeth, paired appendages and jaws (Neidert et al., 2001). There
is a correlation between some of those morphological innova-
tions and Dlx gene family expansion and expression modifica-
tion (Depew et al., 2002). The vertebrate Dlx genes, which
encode a family of homeobox-containing transcription factors
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doi:10.1016/j.ydbio.2008.01.001product, constitute one example of functional diversification of
paralogs (Ghanem et al., 2003). Gnathostoma vertebrates have
six Dlx genes organized into pairs of closely linked,
convergently transcribed loci, Dlx1–Dlx2, Dlx3–Dlx4 (origin-
ally called Dlx7) and Dlx5–Dlx6, each located in close
proximity to one of four Hox clusters in the mouse genome.
Because the original duplication event that created the first
linked pair of genes happened a considerable evolutionary time
before the subsequent replication events that produced the three
pairs that exist in mammals and birds, Dlx2, Dlx3 and Dlx5 are
more closely related to each other than they are to Dlx1, Dlx4
and Dlx6 (Neidert et al., 2001; Stock, 2005; Stock et al., 1996).
They are expressed in distinct but overlapping domains,
primarily in the forebrain, branchial arches and tissues derived
from epithelial–mesenchymal interactions (Bendall and Abate-
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Bryan and Morasso, 2000). Overlapping patterns of expression
of members of a gene pair can be conferred by cis-acting
regulatory sequences located in the regions between gene pairs
(Ghanem et al., 2003).
Dlx5 and Dlx6 are expressed in a generally similar pattern
and are expressed in almost every skeletal element, including
endochondral and membranous bone (Chen et al., 1996;
Simeone et al., 1994; Zhao et al., 1994). The impression from
these studies was that, in general, Dlx5 is expressed at higher
levels than Dlx6, although the techniques used were not
quantitative. Dlx5 overexpression accelerates osteoblast differ-
entiation of primary osteoblast cultures derived from chick
calvariae (Tadic et al., 2002), and it can induce expression of the
Col1a1 promoter (Tadic et al., 2001). Dlx5 knockout mice
display significant craniofacial and sensory capsule skeletal
defects as well as delayed calvarial ossification and less well
organized diaphyseal cortical bone (Depew et al., 1999;
Acampora et al., 1999). All these data suggest that Dlx5 plays
an important role in osteoblast differentiation; however, the
limbs and axial skeleton of Dlx5 knockout mice are relatively
normal. This raises the possibility that other Dlx genes
compensate for the absence of Dlx5 in these mice. Interestingly,
Dlx5/6 knockout mice have a more severe bone phenotype than
the Dlx5 single knockout, with craniofacial, axial and
appendicular skeletal abnormalities (Robledo et al., 2002); in
addition, this knockout produced a jaw phenotype that was
interpreted as being a transformation of the maxilla into a
mandible-like structure (Koentges and Matsuoka, 2002;
Robledo et al., 2002). Although many of these defects are
thought to reflect aberrant pattern formation, it was also
suggested that there may be delayed ossification in the mutant.
Inactivation of Dlx3 in mice resulted in placental failure, so that
the embryonic phenotype could not be investigated (Morasso et
al., 1999); however, a frameshift deletion in the human DLX3
gene causes a hereditary disease, tricho-dento-osseous (TDO)
syndrome, which is characterized by increased bone density
(Haldeman et al., 2004; Price et al., 1998, 1999). This suggests
the potential involvement of Dlx3 in bone development.
Because of the above considerations, we investigated the
possibility that other Dlx genes expressed in bone have the
ability to stimulate osteoblast differentiation. We examined
expression of all six Dlx genes during mouse osteoblast
differentiation by quantitative real-time PCR. Dlx3 is the only
family member that is highly upregulated during differentiation,
while Dlx2, Dlx6 and Dlx5 are expressed in intermediate levels
and Dlx4 and Dlx1 expressed at levels that are difficult to
distinguish from background. To assess the ability of these genes
to stimulate osteoblast differentiation, chick and mouse Dlx6
and chick Dlx3 cDNAs were cloned into RCASBP(A), an avian
replication-competent retroviral vector. We cloned murine Dlx6
mRNA that contains a long poly-glutamine/poly-proline tract
that is not present in the chick, Xenopus or zebrafish proteins.
We also cloned an N-terminal truncated form of the mouse
mRNA that lacked the poly-glutamine/poly-proline tract, in
which translation is initiated at an internal AUG. Primary chick
and mouse calvarial cells and mouse marrow stromal cells(MSC) were infected with the chick Dlx3, chick Dlx6 or mouse
Dlx6 vector, respectively. Our results show that Dlx3 induces
osteoblastic differentiation in all of these cell types with an
apparent efficiency comparable to that of Dlx5. Both forms of
Dlx6 also stimulated osteoblastic differentiation. These studies
suggest that Dlx3 may be a critical Dlx gene for inducing the
later stages of osteoblastic lineage progression and possible
osteocyte function, and that Dlx6, which is in a different class of
Dlx genes from that of Dlx2, Dlx3 and Dlx5, is also capable of
stimulating osteoblast differentiation. Our results provide
important clarification of the expression levels and possible
functions of the Dlx genes during osteoblast differentiation.Materials and methods
Preparation of calvarial osteoblast cell culture and viral transduction
Calvarial cells were isolated from 7-day-old CD1 neonatal mice or 15-day-
old chick embryos (Charles River SPAFAS, North Franklin, CT, USA) using a
modification of the method described by Wong and Cohn (1975) (Kalajzic et
al., 2002; Tadic et al., 2002). Calvariae were subjected to four sequential 15-
min digestions in an enzyme mixture containing 0.05% trypsin and 1.5 U/ml
collagenase P at 37 °C. Cell fractions 2–4 were pooled and enzyme activity
was terminated by addition of media containing FBS. Cells were plated at a
density of 1.5×105 cells/well in 6-well culture dish in DMEM with 10% FBS
and switched to differentiation medium (αMEM containing 10% FBS, 50 μg/
ml ascorbic acid, 4 mM β-glycerophosphate) when they reached confluence.
Cells were infected once a day for 3 days with 0.5 ml conditioned media
containing RCASBP(A), RCASBP(A)Dlx3, RCASBP(A)Dlx5 or RCASBP
(A)Dlx6 mixed with 1.5 ml of fresh media per well beginning on the day after
plating. Cells were harvested for analysis of bone markers at different stages of
differentiation.
Preparation of mouse marrow stromal cell (MSC) cultures and viral
transduction
Two-month-oldβAKE transgenicmicewere sacrificed by CO2 asphyxiation.
Marrow stromal cells were prepared using a previously described procedure
(Kalajzic et al., 2002). Briefly, the epiphyseal growth plates of femurs and tibias
were removed, and the marrow was collected by flushing with αMEMwith 10%
FBS. Cells were plated at a density 5×106 cells/well in 6-well culture plates. On
day 4, the media, along with the nonadherent cells, were replaced with fresh
αMEM plus 10% FBS; on day 7, total medium was changed into differentiation
medium (αMEM/10% FBS supplemented with 50 μg/ml ascorbic acid, 10−8 M
dexamethasone and 8 mM β-glycerophosphate). Afterwards, differentiation
medium was changed every other day for the duration of the experiment. Cells
were transduced with conditioned media containing virus particles beginning on
day 4. Two transductions were performed each day for 3 days until the cultures
were switched into differentiationmedium. On each day of transduction, the cells
were exposed to 0.5 ml virus mixed with 1.5 ml fresh media in the morning, these
media were replaced with fresh media containing virus after 8 h, and these media
were left on the cells overnight.
RNA extraction from cell cultures and Northern blot analysis
RNA extraction and Northern blotting were performed as detailed in
(Kalajzic et al., 2002). Briefly, total RNAwas extracted from cultures using TRI
Reagent (Invitrogen) according to the manufacturer's instructions. RNA pellets
were redissolved in GTC buffer and further precipitated in isopropanol. Fifteen
micrograms of RNA was separated on a 2.2-M formaldehyde/1% agarose gel
and transferred onto a nylon membrane (Nytran, Schleicher and Schuell).
Membranes were probed with (32P)dCTP-labeled rat Col1a1, mouse OC and
mouse BSP for mouse osteoblast cultures and chick BSP, OC, Dlx3 and Dlx6 for
chicken cultures.
Table1
mRNA expression pattern of Dlx genes in mCOB
Day 2 Day 5 Day 7 Day 14
Dlx1 1.0 0.7 0.9 1.2
Dlx2 32.1 16.2 27.8 29.5
Dlx3 12.6 4.0 28.8 980.4
Dlx4 0.1 0.2 0.7 1.5
Dlx5 3.0 3.5 6.3 19.0
Dlx6 18.6 26.1 59.2 82.6
Value was normalized to Dlx1 mRNA expression at day 2.
460 H. Li et al. / Developmental Biology 316 (2008) 458–470Histochemical analysis of cell cultures
ALP activity staining was performed by using a commercially available kit
(86-R Alkaline Phosphatase, Sigma Diagnostics, Inc. St. Louis, MO, USA)
according to the manufacturer's instructions. von Kossa staining was utilized to
assess mineralization after ALP staining by adding 5% silver nitrate solution at
1 ml/well into 6-well culture plates, which were then irradiated using two Auto
Cross Link cycles in a UV Stratalinker 1800 (Stratagene), washed with water
and air dried.
Real-time PCR
Calvarial cell cultures were prepared from 7-day-old CD1 neonatal mice, and
RNA was extracted using methods described above. cDNA was synthesized
using an Invitrogen Superscript First-strand Synthesis System for RT-PCR.
TaqMan® Gene Expression Assays specific for Dlx genes and marker genes for
osteoblast differentiation were purchased from ABI and performed on the 7500
Real-Time PCR System (assay ID: Dlx1, Mm00438424_m1; Dlx2,
Mm00438427_m1; Dlx3, Mm00438428_m1; Dlx4, Mm0043842858_m1;
Dlx5, Mm00438430_m1; Dlx6, Mm01166201_m1, 18s, 4319413E; DMP1,
Mm01208365_m1; BSP, Mm00492555_m1; OC, Mm00649782_m1). The
TaqMan assays are designed so that they do not detect the antisense Dlx1 and
Dlx6 transcripts that are in the mouse (Liu et al., 1997). 18S ribosomal RNA
was used as internal control. Before using theΔΔCT method for quantification,
validation experiments were performed to demonstrate that the amplification
efficiencies of target genes and the reference gene were approximately equal. Q-
PCR was performed using two sets of independently transcribed cDNAs from
each experiment. Gene expression levels were averaged from two biological
replicates.
Mouse Dlx6 cDNA cloning
Tissue RNA was extracted from C57BL/6 mouse femurs and treated with
DNase to degrade the remaining genomic DNA. The cDNA array was
generated by reverse transcription using SuperScript II and oligo dT
(Invitrogen) according to the manufacturer's instructions with slight
modification. The final reaction (1–0.1 μl) was used for the PCR reaction.
A series of primers were designed according to the mouse genomic sequence
(accession number: AC122240; GI: 50839090) to amplify targeted regions as
shown in Fig. 7A. Primers were the following: sense primer P1: 5′-
TTTATCGATGTGAAAGAAACCCGGGAGA-3′; antisense primer P2:
sequence 5′-TTTATCGATGCCTCCTTCAGAAGCTCCGTA-3′; sense primer
P3: 5′-CTCGCAGCACAGCCCTTACCTCCAGTCC-3′. The PCR fragment
amplified by P1 and P2 was subcloned into a TOPO TA vector (Invitrogen,
Carlsbad, California) and further cloned into an RCAS BP(A) virus vector.
PCR conditions for Dlx6 cDNA amplification using primers P1 and P2 are as
follows: 2.5 U of Invitrogen Pfx Taq polymerase; 5 mM of Mg2+; 0.3 μM
primers of each; 100 ng of cDNA; 94 °C, 4′, 1 cycle; 94 °C, 60ʺ, 55 °C, 60ʺ,
68 °C, 2′, 32 cycles.
Retroviral vectors and retrovirus production
The coding sequence of chicken Dlx3 gene was amplified by PCR from
plasmids kindly supplied by M. Kessel (Max-Planck Institute, Göttingen,Fig. 1. Dlx gene expression in lineage marker FACS-sorted cells. Calvarial osteoblast
rat Col1a1 promoter (Col3.6 GFP), the 2.3-kb Col1a1 promoter (Col2.3 GFP) or the D
markers at day 7 for pOBCol3.6GFP cultures (A), at day 17 for pOBCol2.3GFP cult
contrast and florescent image of day 7 calvarial culture from Col3.6GFP transgenic
shows re-analysis of sorted populations. (B) Day 17 calvarial osteoblast culture from
(2.3+) represent mature osteoblasts. (C) Day 19 calvarial osteoblast culture from DM
represent preosteocytes and osteocytes. (D) Northern blot analysis of RNA extracted
(A and B) to detect osteoblast markers, showing enrichment in GFP+ cells. Col1a1, α
protein 1. (E) Real-time PCR analysis of RNA extracted from GFP-positive and -nega
have 40 times enrichment of DMP1 gene expression, around five times more BSP ex
cells. (F) Quantitative real-time RT-PCR was performed to study Dlx gene expressi
expression levels of unsorted day 7 populations. Error bars are the standard deviatioGermany) in order to remove 5′ and 3′ untranslated regions. Pfu polymerase
(Stratagene, La Jolla, CA, USA) was used and the blunt-end product was cloned
into Zero-Blunt vector (Invitrogen, Carlsbad, CA, USA) and then placed into
RCASBP(A), a helper-independent avian retroviral vector using the Gateway
cloning system (Life Technologies, Rockville, MD, USA).
Dlx6 cDNA was amplified by RT-PCR from total RNA extracted from
chicken long bone, using primers designed from the sequence of a cosmid
clone that contains the chicken Dlx6 gene. Superscript II (Invitrogen,
Carlsbad, CA, USA) was used for reverse transcription and Taq polymerase
for PCR Invitrogen, Carlsbad, CA, USA). The amplified fragment was cloned
into a modified Bluescript vector and sequenced. The sequence of this clone
was identical to the sequence submitted to GenBank by S. Brown and A.
Groves, accession number AY640308, except for a base variation at
nucleotide 813 from a C to a T, which converts a proline to a leucine. This
amino acid is downstream of the homeodomain, and its functional significance
is not known. We confirmed the sequence of our clone by PCR amplifying
and sequencing the Dlx6 cDNA from chick osteoblast RNA and found the
sequence identical to our cDNA clone. We did not detect any sequences that
matched AY640308 at nucleotide 813. The AY640308 sequence may
represent a polymorphism or a sequencing error. Because we confirmed that
the clone we had isolated was a true wild-type sequence, we chose to use it
for our functional studies. Our cDNA was cloned into the ClaI site of the
RCASBP(A) retroviral vector. Control virus was RCASBP(A) vector without
inserted cDNA. Vectors were transfected (Lipofectamine 2000, Life
Technologies, Rockville, MD, USA) into the DF1 producer cell line (chicken
embryonal fibroblasts). Cells were expanded by splitting multiple times.
Conditioned media from transfected cells were collected when cells became
superconfluent and stored at −70 °C. Virus production was confirmed by
Reverse Transcriptase Assay (Roche). Virus titer was acquired by performing
immunohistochemistry using antibody against pGAG (AMV-3C2, Develop-
mental Studies Hybridoma Bank). In general, virus titer was between 6×107
and 6×108.
Preparation of nuclear extracts and Western immunoblotting
Nuclear extracts of day 7 calvarial cultures were produced based on the
procedures of Shapiro et al. (1988). Twenty-five micrograms of protein was
separated on SDS–PAGE gels, transferred to nitrocellulose membranes, and
blots were probed with a polyclonal rabbit anti-human Dlx6 antibody (Aviva
Systems Biology, San Diego, CA) under manufacturer's instructions.
Antibody binding was visualized using the ECL Plus system (GE
Healthcare).cultures were derived from transgenic mice containing GFP driven by the 3.6-kb
MP1 promoter (DMPGFP). Calvarial osteoblasts were sorted according to GFP
ures (B) or at day 19 for DMP1GFP cultures (C). (A) Upper panel shows phase
mice. Col3.6 GFP-positive cells (3.6+) represent preosteoblasts. Lower panel
Col2.3GFP mice and re-analysis of cells after sorting. Col2.3 GFP-positive cells
P1GFP mice and re-analysis of sorted cells. DMP1 GFP-positive cells (DMP1+)
from GFP-positive, GFP-negative populations or unsorted cells generated from
I type I collagen; BSP, bone sialoprotein; OC, osteocalcin; DMP-1, dentin matrix
tive populations in DMP1 cultures showed in panel C. DMP1-GFP-positive cells
pression and two times the amount of OC expression compared to the negative
on in the sorted cells. For each gene, expression levels were normalized to the
n of triplicate assays from the same RNA sample.
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The 600-bp antisense Dlx3 riboprobe was prepared by in vitro transcription
of linearized chick Dlx3 cDNA using T7 RNA polymerase (Life Technologies,
Rockville, MD, USA). Nonspecific hybridization signals and emulsion
background were controlled for by hybridization of adjacent tissue sections
with nonspecific riboprobe or with no probe at all. Whole calvaria from 15-day-
old and mandibles from 10-day-old chick embryos were isolated, fixed in 4%
paraformaldehyde at 4 °C overnight, washed and dehydrated using methanol.
Tissues were embedded in paraffin, sectioned at 7-μm thickness and processed
for in situ hybridization using [32P] UTP-labeled riboprobes. The sections were
stained with hematoxylin, mounted, examined and photographed using an E600
Nikon microscope and a Spot RT TM camera. In the studies of Dlx3 expression
in 18-day-old mouse mandible, paraffin sections were prepared as described
above. Dlx3 antisense and sense RNA probes used for hybridization were
prepared from an XhoI and NotI linearized pBluescript II SK Dlx3 subclone and
transcribed in vitro in the presence of digoxigenin-U-NTP mixture (Roche #
11277073910) with T3 and T7 polymerase, separately.
Preparation of cells for sorting
Cells were prepared for sorting as previously described (Kalajzic et al.,
2005). Briefly, 7-day-old Col3.6(GFP) calvarial osteoblast cultures were
digested in 0.25% trypsin, 1 mM EDTA for 5 min. Seventeen-day-old Col2.3
(GFP) culture or 19-day-old DMP1(GFP) cultures were digested in 0.2%
collagenase A (Roche), 0.2% hyaluronidase and 2.5% trypsin for 10–15 min.
Cell sorting was done using a FACS Vantage (BD Biosciences) with 488 nm
excitation and 530/30 emission filters. Cells were separated using a 100-μm
nozzle and collected into DMEM/30% FBS media. Prior, during and following
sorting the cell suspensions were kept cold to minimize changes in gene
expression.Results
Relative quantification of Dlx gene expression during
osteoblast differentiation
To assess the potential for functional redundancy of Dlx
genes in bone development, we wished to study the expression
and potential role of Dlx genes in bone tissues and in
osteoblastic cell cultures and to have a more comprehensive
understanding of the relative expression levels of the Dlx genes
at different stages of osteoblastic differentiation. To address this
question, we carried out an analysis of the expression of all of
the Dlx genes in cultured mouse calvarial osteoblasts at several
time points using quantitative real-time PCR. Because the
amplification efficiency of all of the primer pairs used for the
study was similar and all CT values were normalized to the
same internal standard, we can also compare expression levels
of different Dlx genes at the mRNA level. Dlx3 was expressed
at low to moderate levels in the proliferating phase of the
cultures and demonstrated a dramatic increase as the cultures
differentiated (Table 1). Somewhat surprisingly, unlike the
impression from previous in situ hybridization studies (Simeone
et al., 1994), Dlx6 was expressed at levels that were greater than
Dlx5. Dlx2 was expressed at levels generally comparable to
Dlx6, while Dlx1 and Dlx4 were expressed at levels that were
so low that they may represent background PCR signal. Dlx2
and 6 levels increased somewhat as the cultures differentiated,
and Dlx5 increased to a greater degree, but the increases in Dlx3
levels were much more extreme.Primary osteoblast cell cultures are heterogeneous with a
high proportion of cells that are not in the osteoblast lineage. In
addition, osteoblast lineage cells at various levels of maturation
are present at any given time of culture. Thus, amplification of
gene expression in such mixed cultures represents the average
gene signal derived from a very heterogeneous population and
may not accurately reflect changes in expression during the
maturation of the osteoblast lineage.
To further analyze Dlx gene expression in more defined
osteoblastic populations, we quantified Dlx gene expression
levels in FACS-sorted cultured mouse calvarial osteoblasts. The
use of transgenic GFP markers to label cells in different stages
of osteoblast lineage has been extensively studied in our lab. It
has been demonstrated that in early osteoblast cultures, the 3.6-
kb type I collagen promoter directs GFP expression to cells that
are at an early stage of osteoblast differentiation. In contrast, the
2.3-kb of type I collagen promoter activates when osteoblast
cell cultures begin to form mature osteoblastic nodules.
Isolation of Col2.3GFP-positive cells by flow cytometry and
Northern blot analysis has shown that these cells are highly
enriched for markers of osteoblast differentiation including
osteocalcin and bone sialoprotein mRNA (Kalajzic et al., 2002),
indicating that they possess a mature osteoblastic phenotype. In
addition, activation of dentin matrix protein 1 (Dmp1) directed
GFP is closely associated with the preosteocyte and osteocyte
stages (Figs. 1D and E) (Kalajzic et al., 2004; Yang et al., 2005).
In summary, the 3.6-kb collagen I promoter (Fig. 1A), the 2.3-
kb collagen I promoter (Fig. 1B) and the DMP1 promoter (Fig.
1C) drive GFP expression in preosteoblasts, mature osteoblasts
and osteocytes, respectively (Figs. 1A–E). We sorted different
stages of osteoblasts from primary calvarial cell cultures derived
from transgenic mice using these markers. Dlx gene's
expression patterns were measured in these populations using
real-time PCR (Fig. 1F). Dlx2, Dlx5 and Dlx6 were more
enriched in Col3.6GFP-positive cells from 7-day-old cultures,
which represent preosteoblasts, but were more highly expressed
in Col2.3GFP-negative cells than in Col2.3GFP-positive cells
from 17-day-old cultures, suggesting that these Dlx genes begin
to be downregulated as osteoblasts attain the fully differentiated
state. Dlx3 exhibited very high levels of expression in
Col2.3GFP and DMP1GFP-positive cells, which represent
mature osteoblasts and osteocytes (Figs. 1D–E).
Dlx3 mRNA expression and its effects in osteoblast
differentiation
Because of the distinctive expression pattern of Dlx3, we
wished to explore patterns of Dlx3 expression in vivo and its
possible roles in osteoblast differentiation.
RT-PCR revealed the presence of Dlx3 mRNA in total RNA
of chick long bone, calvaria and skin as well as in RNA from
chick calvarial osteoblast cultures at days 13 and 20, when cells
are at a more differentiated stage (Fig. 2A). No expression was
seen in the brain, the heart or the liver. Northern blot analysis of
mouse tissues showed that Dlx3 signal is present in bone and
tail (Fig. 2B); expression in tail may reflect expression in both
vertebral bone and skin. In chick calvarial cultures Dlx3
Fig. 2. Dlx3 mRNA presence in bone and osteoblast culture. RT-PCR was
performed on total RNA extracts from different tissues and cultured chicken
primary calvariae for detection of Dlx3mRNA, as well as Northern blot analysis
of cultured primary cells from chicken and mouse calvariae, mouse bone
marrow stromal cells, long bone, bone marrow, tail and tendon. (A) RT-PCR
showing the presence of Dlx3 mRNA in chick calvaria, long bone, skin and at
more differentiated stages of cultured osteoblastic cells (cCOB), but not in the
brain, the heart or the liver. (B) Northern blot analysis detected Dlx3 mRNA in
mouse long bone and tail but not in bone marrow and tendon. (C) Northern blot
of chicken calvarial cultures showing the presence of Dlx3 mRNA at days 13
and 20. (D) Northern blot of mouse calvarial (mCOB) and marrow stromal
(mMSC) cultures showing the presence of Dlx3 signal from day 18.
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mouse calvarial and marrow stromal cultures from day 18 (Fig.
2D), a time when cultures become osteogenic and expressed
markers of mature osteoblasts such as osteocalcin and BSP (data
not shown). To further assess expression of Dlx3 in bone,
calvaria of 15-day-old chick embryos were hybridized with a
Dlx3 antisense riboprobe. Dlx3 signal was detected in the
osteogenic cells in the periosteum and in the osteogenic cells
lining the bone marrow spaces (Figs. 3A–E). The Dlx3 signal
was also present in condensing preosteogenic mesenchyme and
periosteal osteogenic cells of mandible sections from 8- to 10-
day-old chick embryos (Figs. 3F–I). We further studied Dlx3
expression in 18-day-old mouse mandible by in situ hybridiza-
tion (Figs. 3J and K). In agreement with a previous study
(Ghoul-Mazgar et al., 2005), Dlx3 transcripts were detected in
the osteoblasts and newly formed osteocytes; however, we also
detected Dlx3 mRNA expression in well-differentiated osteo-
cytes (Fig. 3K).
To evaluate the ability of Dlx3 to regulate osteoblast
differentiation, we tested the effect of overexpression of Dlx3
in primary chick calvarial fibroblasts (cCF) and osteoblasts
(cCOB). To obtain cCF, we plated the first fraction of cells
derived from sequential trypsin/collagenase digestion of
calvariae from 15-day-old chick embryos. When grown in
differentiating conditions, cCF fail to differentiate into
osteoblasts, i.e., they do not express markers of late bone
differentiation markers such as osteocalcin or form mineralizednodules (Tadic et al., 2002), but often peel off the dish several
days after they reach confluence. In contrast, cCF cultures
overexpressing Dlx3 displayed a different morphology than
control cells. They appeared more cuboidal and formed
mineralized nodules at day 12, while control cells infected
with RCAS retained a fibroblastic spindle shape (data not
shown).
After infection with RCAS(A) Dlx3, cCF cultures differ-
entiated into osteoblasts, with increased AP staining at day 12
and increased von Kossa staining at days 12 and 14 (Fig. 4C).
Upregulation of type I collagen and osteocalcin was also
observed at days 12 and 14 (Fig. 4A). CCOB, obtained from
fractions 2–4 of these same calvarial digests, were also infected
with RCAS Dlx3. More extensive von Kossa staining was
observed in infected cells along with upregulation of type I
collagen and osteocalcin at day 12 (Figs. 4B and C) when
compared to control cultures.
In addition to our studies in chick calvarial osteoblasts, we
also wished to determine whether mammalian osteoblast
differentiation was regulated by Dlx proteins. We have utilized
bone marrow derived stromal cells that originate from a
different developmental lineage than calvarial osteoblasts. We
isolated MSC from β-AKE mice, a transgenic model that
expresses the receptor for the RCAS(BP)A retroviral vector.
MSC cultures were transduced with vectors expressing Dlx3 or
Dlx5, and RNAwas harvested at various time points. Northern
blot analysis was carried out to test the expression of osteocalcin
and bone sialoprotein (Fig. 5). On day 11 of culture, both Dlx3
and Dlx5 induced expression of both bone markers. At later
time points, the levels of both markers were increased. Similar
induction effects were also observed in mouse calvarial
osteoblast cultures (data not shown). It is interesting that Dlx5
generally induced BSP more strongly than osteocalcin, while
Dlx3 induced osteocalcin more strongly than BSP. This was
observed in several experiments with both chick and mouse
osteoblasts.
Cloning Dlx6 and its effects on osteoblast differentiation
We initially cloned chick Dlx6 cDNA into the RCAS
retroviral vector. Calvarial cultures from 15-day-old chicken
embryos were infected by virus expressing Dlx6 protein.
Northern blot analysis showed upregulation of type I collagen
and osteocalcin (Fig 4D). Increased mineralization is also
detected by von Kossa staining (Fig 4C).
Although chick Dlx6 appears to have a relatively modest
effect on osteoblast differentiation, we considered that mouse
Dlx6 may be more potent because of the strong additional
effects of the Dlx6 knockout when combined with the Dlx5
knockout and due to significant sequence divergence between
the mouse and chick genes. Therefore, we assessed the ability of
mouse Dlx6 to stimulate osteoblast differentiation. In prepara-
tion to these studies, we became aware that no definitive
complete mouse Dlx6 cDNA sequence was available. GenBank
annotation of the Dlx6 gene included a computer analysis
prediction of a translation initiation site at 49 amino acids
upstream of its homeobox domain. However, in-frame genomic
Fig. 3. Expression of Dlx3 in developing chick calvaria and mandible and mouse mandible. Dark-field (A, D) and corresponding bright-field (B, E) images of sagittal
sections through whole calvaria from 15-day-old chick embryos hybridized with the∼600-bp antisenseDlx3 riboprobe. The hybridization signal forDlx3 is present in
the osteogenic cells in the periosteum (indicated by arrowheads) covering the newly formed bone, and in the osteogenic cells lining the bone marrow spaces (indicated
by asterisk) in the more advanced stages of calvarial bone formation. (C) Adjacent section to section shown in panel A stained with hematoxylin and eosin. Dark-field
(F, H) and corresponding bright-field (G, I) images of sagittal sections of mandibles are from 8-day-old (F, G) and 10-day-old (H, I) chick embryo.Dlx3 is expressed in
condensing preosteogenic mesenchyme (indicated by asterisk) and osteogenic cells in the periosteum (indicated by arrowheads). Scale bars: 100 μm. Dlx3 transcripts
were detected in the sagittal section of 18-day-old mouse mandible (J, control probe and K, Dlx3 probe). Mouse Dlx3 mRNA can be detected in osteoblasts,
preosteocytes and osteocytes.
464 H. Li et al. / Developmental Biology 316 (2008) 458–470sequences upstream of this predicted initiation codon encode a
domain containing multiple repeated glutamines and prolines
that is worthy of note. The function of such poly-glutamine/
poly-proline tracts in transcriptional regulation is not clear, but
it may be active in protein binding and related to cell apoptosis
(Perutz et al., 1994). Expansions of poly-glutamine tracts in
proteins that are expressed in the central nervous system cause
neurodegenerative diseases (Ferro et al., 2001). The general
transcription initiator, TATA box binding protein (TBP),
contains N-terminus poly-glutamine repeats that regulate C-terminus DNA binding activity (Nakamura et al., 2001). Pfeffer
et al. (2001) compared the human Dlx6 genomic sequence to
the Xenopus and zebrafish genomic sequences and suggested
that the human Dlx6 protein included the long poly-glutamine
and poly-proline tracts. Information obtained from human
mRNA and mouse genomic sequences were used to predict the
mouse Dlx6 translation start site; however, neither mouse
mRNA nor protein studies were presented. Therefore, we
decided to clone the mouse Dlx6 cDNA based on this
information.
Fig. 4. Effects of retroviral overexpression of Dlx3 and Dlx6 on chicken calvarial fibroblast and osteoblast cultures. cCF—primary calvarial fibroblast (fraction 1) and
cCOB—osteoblast cultures (fractions 2–4) were infected with RCAS Dlx3, RCAS Dlx6 and RCAS (control), and osteoblast differentiation was monitored by alkaline
phosphatase staining, von Kossa staining and Northern blot analysis. Markers of bone differentiation, collagen and osteocalcin are strongly upregulated in cells treated
with Dlx3 in both cCF (A) and cCOB cultures (B). Dlx6 also induced collagen and osteocalcin in cCOB culture at day 12 (B) and day 13, as well as day 21 (D).
Alkaline phosphatase and von Kossa staining (C) reflect results of Northern blot analysis in panels A and B. Both Dlx3 and Dlx6 induce mineralization.
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sequence as indicated to amplify the entire coding region (Fig.
6A). Two PCR products were obtained using primers P1 and P2,Fig. 5. Dlx3 induces mouse marrow stromal cell differentiation. Mouse marrow
stromal cell cultures were infected with virus containing empty vectors or Dlx3
orDlx5 cDNAs. Cell cultures were analyzed at different time points by Northern
blot to detect the expression of bone differentiation makers. Starting from day
14, BSP and OC expression was strongly induced by Dlx3 and Dlx5. Dlx3
always induces OC expression more strongly than Dlx5, whereas Dlx5 induces
BSP more strongly than Dlx3.a fragment of around 1 kb (GenBank accession number
EF535989) as predicted by Pfeffer et al. (2001) and a smaller
fragment of around 0.8 kb (GenBank accession number
EF535990) (Fig. 6C). Primers P3 and P2 produced only one
PCR product, suggesting that the sequence variance is in the
putative first exon region (Fig. 6D). Sequencing of the PCR
product suggested that 146 bp of the first exon was deleted, and
the predicted translational reading frame had a premature stop
codon after amino acid 74. The shorter Dlx6 RNAwas found in
several RNA preps from different tissues. Although initially we
were not sure of the significance of this PCR product, we later
acquire evidence to demonstrate that it is likely to be a PCR
artifact. We found that this band was amplified by PCR using
RNA extracted from chick fibroblasts that were infected with an
RCAS virus vector that expressed the 1-kb cDNA.
We wished to determine whether the size of the native form
of the Dlx6 protein is consistent with translation initiation at the
upstream AUG. We therefore performed Western blot on
nuclear extract from mouse calvarial osteoblasts. A Dlx6-
specific antibody detected a band of approximately 37 kDa (Fig.
6E). This result is consistent with the predicted size of a protein
initiated at 171 amino acids upstream of the homeobox domain.
To study the biological functions of Dlx6, as well as the role
of the glutamine/proline repeats, we generated RCAS virus
containing the 1-kb and 0.8-kb cDNAs; this was done before we
discovered that the 0.8-kb product was a PCR artifact. We also
Fig. 6. Cloning mouse Dlx6. (A) Schematic of mouse Dlx6 gene and primers for cloning the cDNA. A ClaI site was added in the 3′ end for both primers P1 and P2 for
cloning. Lower panel shows the 0.8-kb cDNA amplified from mouse femur RNA. (B) Two bands were amplified by RT-PCR for Dlx6 using primer P1 and P2. (C)
Only one band was detected by RT-PCR using primer P3 and P2. (D)Western blots ofDlx6-positive control, Jurkat cell lysate (human T-lymphocytes from acute T-cell
leukemia, Aviva Systems Biology) and nuclear extract from day 7 mouse calvarial osteoblast cultures were blotted by Dlx6-specific polyclonal antibody. A slightly
larger Dlx6 protein was detected in mouse.
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containing only the more 3′AUG, which produces a protein that
does not contain the poly-glutamine/poly-proline repeat
sequences. Although this form of the protein is not expressed
endogenously, we used this vector to carry out an initial test of
the importance of the N-terminal region of the Dlx6 protein that
contains the repeats for induction of osteoblast differentiation.
Empty RCAS vector was used as a control, and the 0.8-kb
expressing vector, which has not produced any biological effect
in any of our experiments, in effect served as a second negative
control. The phenotypes from DF1 cultures transduced with
virus containing 1 kb or 0.6 kb were similar. Cells from these
cultures show dramatic decreases in cell number, lose their
fibroblastic phenotype and become cuboidal in shape compared
to uninfected cell cultures, RCAS(A) or the 0.8-kb Dlx6 virus-
transduced cultures (Fig. 7A). Similar morphological changes
have been observed in all DF1 cultures that have been
transduced withDlx3 orDlx5 containing virus (data not shown).
We observed a strong induction of osteoblast differentiation
when mouse marrow stromal cell cultures were transduced with
0.6 kb Dlx6 containing virus. More von Kossa-positive nodules
were present (Figs. 7B and C), and induction of BSP and OC
expression was detected by real-time PCR (Fig. 7D). Even
stronger induction of osteoblast differentiation was observed
from cultures transduced with the 1-kb full-length Dlx6 cDNA
(Figs. 7D and E). Quantification of bone markers showed a 19-
fold induction of OC and a 10-fold induction of BSP expressionin day 18 cultures (Fig. 7F). In other experiments, the induction
of osteoblast markers by the full-length sequence was not as
great, while the level of induction by the 0.6-kb form was more
consistent. This could be because the 1-kb full-length Dlx6
cDNA is not as consistently expressed from the RCAS vector as
the 0.6-kb cDNA (data not shown). This could be a reason for
lower induction of differentiation in some cultures transduced
by full-length Dlx6. Our studies indicate that the poly-
glutamine/poly-proline repeat domain is not necessary for
transcriptional activation of bone differentiation markers;
however, it may enhance the strength of induction.
Discussion
Previous Dlx5 overexpression studies showed that Dlx5 can
induce osteoblastic differentiation in osteoblastic cell culture
(Miyama et al., 1999; Ryoo et al., 1997; Tadic et al., 2002). It
has also been shown that Dlx genes are mediators of the BMP2
induction of osteoblast regulatory genes including Runx2 and
Osterix (Harris et al., 2003; Lee et al., 2003a,b).
Dlx5 knockout mice suffer from craniofacial and sensory
capsule skeletal defects (Acampora et al., 1999; Depew et al.,
1999), while simultaneous disruption of Dlx5 and Dlx6 in mice
results in a more severe craniofacial phenotype (Robledo et al.,
2002). Knockouts of Dlx1 and Dlx2 show primarily craniofacial
defects (Qiu et al., 1997; Qiu et al., 1995). Although many of
the effects of Dlx gene knockouts on the skeleton are patterning
Fig. 7. Dlx6 induces mouse marrow stromal cell differentiation. RCAS virus was generated containing mouse 0.6-kb, 0.8-kb or full-length 1-kb Dlx6 cDNA. Virus
containing empty vector was used as control. (A) Morphological changes in DF1 cultures when transduced with virus. Phenotypes of cells overexpressing 0.6-kbDlx6
cDNA or 1-kbDlx6 cDNAwere similar. Cultures have decreased cell number, lose of the elongated fibroblastic phenotype and become cuboidal. Cells transduced with
empty virus vector or 0.8-kb Dlx6 cDNA show no morphological changes compared with untreated cells. (B, C, D) Mouse marrow stromal cells from βAKE mice
were transduced with virus containing 0.6-kb, 0.8-kb and 1-kb mouse Dlx6 cDNA. Cultures were stained for alkaline phosphatase and von Kossa at the indicated days
after plating. More and stronger von Kossa staining nodules were observed in cultures overexpressing 0.6-kb and 1-kb mouse Dlx6. Mineralized areas in the day 18
cultures were quantified in panel C (*P≤0.05). (D) Real-time PCR quantification of the osteoblast differentiation makers fromDlx6 overexpressing cultures. The 0.6-
kb mouse Dlx6 and the full-length mouse Dlx6 dramatically induce BSP and OC expression.
467H. Li et al. / Developmental Biology 316 (2008) 458–470defects, these studies suggest that Dlx genes also play a direct
role in stimulating osteoblast differentiation. The effects of
individual Dlx genes may be compensated for by expression of
other Dlx genes in differentiating osteoblasts.
To evaluate this possibility, we examined the relative
expression of the various Dlx genes in osteoblasts at different
stages of differentiation. Our initial prediction would be that
genes that are expressed at higher levels in differentiating
osteoblasts are more likely to be important for differentiation. In
situ hybridization, Northern blot or standard PCR cannot be used
to make reliable comparisons of expression levels of different
genes because the efficiency of detection of different mRNAs is
difficult to assess. Real-time PCR has a greater potential to allow
quantitative comparison of different mRNA levels because the
efficiency with which primer pairs amplify different mRNAs canbe assessed and optimized so that they are very close to 100%. In
unsorted calvarial osteoblast cultures, Dlx1 and Dlx4 mRNAs
were almost nondetectable, while Dlx2, Dlx5 and Dlx6 were
expressed at comparable levels to each other, and their
expression in general was somewhat upregulated concomitant
with the maturation of the cultures. Dlx3 showed the highest
expression level in the most mature osteoblast cultures. We
confirmed the presence of Dlx3 in osteoblasts using in situ
hybridization, Northern blot and PCR. High-resolution in situ
hybridization demonstrated expression of Dlx3 in osteoblasts,
preosteocytes and some mature but not all osteocytes. This is in
partial contrast to the studies of (Ghoul-Mazgar et al., 2005) who
showedDlx3 expression in osteoblasts, immature osteocytes but
not mature osteocytes. Thus, we speculate that Dlx3 may play a
role in regulating osteocyte function.
468 H. Li et al. / Developmental Biology 316 (2008) 458–470Osteoblast cultures contain mixed cell types. Although late
stage calvarial cultures include increasingly differentiated
osteoblasts, a significant proportion of the cells are not in the
osteoblastic lineage. The study of gene expression in a whole
cell population can be misleading. To study Dlx genes
expression in pure cell types, we analyzed FAC-sorted cells.
The use of an osteoblast lineage-specific promoter to drive
GFP expression provides us with the ability to separate
preosteoblasts, mature osteoblasts plus osteocytes and osteo-
cytes alone from cultures with mixed cell types. A model of
our current belief, based on the data from FAC-sorted cells
concerning changes in the levels of Dlx mRNAs during
osteoblast differentiation, is shown in Fig. 8. Some of these
conclusions are more strongly supported by the evidence than
others. The most strongly supported conclusions are that Dlx3
mRNA is present at the highest levels in differentiated
cultured calvarial osteoblasts and osteocytes and shows the
greatest degree of upregulation during differentiation. Our
real-time PCR studies are supported by microarray studies
showing that Dlx3 is very highly expressed in Col2.3GFP-
positive cells from differentiated calvarial osteoblast cultures
but is present at much lower levels in 17-day-old cultures and
in Col2.3GFP-negative osteoblasts (Kalajzic et al., 2005). In
general, expressions of Dlx2, Dlx5 and Dlx6 were increased
as cultures matured, peaking in the day 17 Col2.3GFP-
negative cells; however, their expression is decreased in more
differentiated Col2.3GFP-positive osteoblasts. It should be
noted that the Col2.3GFP-negative population contains both
immature osteoblasts and cells that are not in the osteoblast
lineage. We believe that it is probable that Dlx genes are
primarily expressed in osteoblast lineage cells in calvarial
cultures, so if anything, we are probably underestimating theFig. 8. Model for Dlx gene expression during osteoblast differentiation. We summa
horizontal axis represents the osteoblast maturation along the osteoblast lineage, wh
schematically represents the mRNA expression level of each Dlx gene. Dlx2, Dlx5
osteoblast population, whereas Dlx3 is dramatically enriched in the mature osteoblaexpression of Dlx genes in immature osteoblasts, but this has
not been proven.
There appear to be subtle differences in the expression of
Dlx2, Dlx5 and Dlx6. Dlx2 appeared to be expressed slightly
earlier than 5 and 6 and to be downregulated more strongly at
later stages. Dlx6 expression seemed to be maintained at higher
levels at more mature differentiation stages.
RCAS retroviral expression in chick and mouse calvarial
osteoblasts and in mouse MSC cultures showed that chick Dlx3
appears to be a potent inducer of osteoblast differentiation, with
activity comparable to Dlx5. A definitive comparison of the
potency of Dlx3 versus Dlx5 cannot be made because we do not
have antibodies to chick Dlx3 or 5 to assess levels of protein
expression. We chose not to fuse an epitope tag to our expressed
proteins because of concern that the tag might affect the
function of the protein. It is interesting that Dlx3 seemed to
consistently activate expression of osteocalcin more strongly
than BSP, while Dlx5 more strongly induces BSP. This is
consistent with our observation that Dlx3 is highly upregulated
in differentiated cells, while Dlx5 is present at earlier stages of
differentiation and is downregulated during terminal osteogenic
differentiation.
While this manuscript was in preparation, a study was
published which also suggests that Dlx3 plays an important role
in inducing osteoblast differentiation (Hassan et al., 2004).
These studies showed that Dlx3 is present in osteoblasts,
stimulates osteoblastic differentiation and binds to the osteo-
calcin promoter. Their chromatin immunoprecipitation studies
indicate that Dlx5 displaces Dlx3 from the OC promoter in late
stages of differentiation. This contrasts with our results,
indicating that Dlx3 mRNA is most strongly induced at later
stages of differentiation, and our observation that Dlx3 appearsrize Dlx genes mRNA expression levels during osteoblast differentiation. The
ich can be identified by activation of stage-specific promoters. The vertical axis
and Dlx6 have relatively higher expression in the preosteoblast and immature
sts and osteocytes.
469H. Li et al. / Developmental Biology 316 (2008) 458–470to stimulate OC expression more strongly than BSP. At this
point, the reasons for this discrepancy are not clear; possibilities
include that Dlx3 and Dlx5 protein levels are posttranscription-
ally regulated in an inverse manner during late differentiation,
or that other transcriptional factors induced late in osteoblast
differentiation favor binding of Dlx5 but not Dlx3 to the
osteocalcin promoter.
Another important conclusion of these studies is that Dlx6
mRNA is expressed at relatively high levels in osteoblasts and
can stimulate osteoblastic differentiation. This is significant
because Dlx6 is in a different class of Dlx genes from the Dlx
genes that have been previously shown to be capable of
inducing osteoblast differentiation, and thus the protein
sequence outside of the homeodomain shows much less
sequence conservation that exists between Dlx3 and Dlx5. In
addition, mouse Dlx6 contains a fairly long glutamine–proline
repeat; the chick protein contains glutamine and proline repeats,
but they are much shorter. Variations in repeat length have been
detected in the analogous sequence in the human gene, and it
has been suggested to have the potential for CAG repeat-
mediated expansion (Ferro et al., 2001). We speculate that since
stretches of glutamines and prolines have been shown to have
transcriptional activation activity, the presence of this domain
may contribute to the possible greater ability of mouse Dlx6 to
activate osteoblast differentiation than chick Dlx6. Our initial
studies on primary mouse marrow stromal cultures transduced
by Dlx6 expressing virus indicated that while the poly-
glutamine/proline repeats are not necessary for the proteins
transcriptional regulation of bone differentiation markers, they
may enhance the strength of induction of these markers. A more
in depth series of studies will be required to assess the role of
these repeats in the ability of Dlx6 to promote osteogenesis. It is
possible that the repetitive RNA sequence that encodes the
amino acid repeats may not be stable during the retroviral life
cycle of the RCAS vectors, so a different expression system
may be needed to assess Dlx6 function. In any case, our results
showing the osteogenic ability of Dlx6, coupled with our
observation that Dlx6 is expressed at similar or greater levels
than Dlx5 in osteoblasts, may help explain the observation that
the Dlx5/Dlx6 double knockout has greater defects in skeletal
development than the single Dlx5 knockout.
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